{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T08:20:17Z","timestamp":1794298817108,"version":"4.9.0"},"reference-count":124,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.jhep.2023.10.015","type":"journal-article","created":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T04:17:03Z","timestamp":1698121023000},"page":"335-351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":109,"title":["Artificial intelligence-assisted digital pathology for non-alcoholic steatohepatitis: current status and future directions"],"prefix":"10.1016","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3051-0111","authenticated-orcid":false,"given":"Vlad","family":"Ratziu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5867-2131","authenticated-orcid":false,"given":"Marcus","family":"Hompesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Petitjean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7592-4668","authenticated-orcid":false,"given":"Cindy","family":"Serdjebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janani S.","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil V.","family":"Parwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0502-4381","authenticated-orcid":false,"given":"Elisabetta","family":"Bugianesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Cusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1178-6195","authenticated-orcid":false,"given":"Scott L.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4234-224X","authenticated-orcid":false,"given":"Eric","family":"Lawitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8494-8947","authenticated-orcid":false,"given":"Manuel","family":"Romero-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4972-1293","authenticated-orcid":false,"given":"Detlef","family":"Schuppan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Loomba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Paradis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Behling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun J.","family":"Sanyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2023.10.015_bib1","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jhep.2021.02.034","article-title":"Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort","volume":"75","author":"Harrison","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.10.015_bib2","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jhep.2023.03.040","article-title":"Global incidence of non-alcoholic fatty liver disease: a systematic review and meta-analysis of 63 studies and 1,201,807 persons","volume":"79","author":"Le","year":"2023","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.10.015_bib3","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jhep.2021.05.022","article-title":"Burden of non-alcoholic fatty liver disease in asia, the Middle East and North africa: data from global burden of disease 2009-2019","volume":"75","author":"Golabi","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.10.015_bib4","series-title":"Noncirrhotic nonalcoholic steatohepatitis with liver fibrosis: developing drugs for treatment guidance for industry","author":"Usa Food and Drug Administration","year":"2018"},{"key":"10.1016\/j.jhep.2023.10.015_bib5","series-title":"Reflection paper on regulatory requirements for the development of medicinal products for chronic non 6 infectious liver diseases","year":"2018"},{"key":"10.1016\/j.jhep.2023.10.015_bib6","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1053\/j.gastro.2021.10.051","article-title":"Expert panel review to compare FDA and EMA guidance on drug development and endpoints in nonalcoholic steatohepatitis","volume":"162","author":"Loomba","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2023.10.015_bib7","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jhep.2022.04.002","article-title":"Breakthroughs in therapies for NASH and remaining challenges","volume":"76","author":"Ratziu","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.10.015_bib8","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.jhep.2020.06.025","article-title":"Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials","volume":"73","author":"Davison","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.10.015_bib9","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/hep.29721","article-title":"Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis","volume":"68","author":"Younossi","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.10.015_bib10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1053\/j.gastro.2020.05.046","article-title":"Why do so many nonalcoholic steatohepatitis trials fail?","volume":"165","author":"Ratziu","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2023.10.015_bib11","article-title":"Artificial intelligence in liver diseases: improving diagnostics, prognostics and response prediction","volume":"4","author":"Nam","year":"2022","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2023.10.015_bib12","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/joim.13030","article-title":"Artificial intelligence as the next step towards precision pathology","volume":"288","author":"Acs","year":"2020","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.jhep.2023.10.015_bib13","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/PAI.0000000000000930","article-title":"Quantitative image analysis for tissue biomarker use: a white paper from the digital pathology association","volume":"29","author":"Lara","year":"2021","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.jhep.2023.10.015_bib14","doi-asserted-by":"crossref","DOI":"10.1177\/2632010X231162317","article-title":"Second-harmonic generated quantifiable fibrosis parameters provide signatures for disease progression and regression in nonalcoholic fatty liver disease","volume":"16","author":"Ng","year":"2023","journal-title":"Clin Pathol"},{"key":"10.1016\/j.jhep.2023.10.015_bib15","doi-asserted-by":"crossref","first-page":"S481","DOI":"10.1016\/S0168-8278(22)01293-4","article-title":"Quantitative digital pathology of 3D human NASH models establish continuous scores to evaluate the antifibrotic effects of selonsertib, firsocostat and resmetiron","volume":"76","author":"Petitjean","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2023.10.015_bib16","doi-asserted-by":"crossref","first-page":"S493","DOI":"10.1016\/S0168-8278(22)01317-4","article-title":"Magnetic resonance elastography (MRE) demonstrate the strongest correlation with digital pathology and NASH CRN fibrosis assessments, compared to transient elastography and other assessed non-invasive tests (NITs)","volume":"77","author":"Martic","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2023.10.015_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-22902-w","article-title":"Automated whole slide image analysis for a translational quantification of liver fibrosis","volume":"12","author":"Serdjebi","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2023.10.015_bib18","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/hep.21595","article-title":"Progression of fibrosis in advanced chronic hepatitis C: evaluation by morphometric image analysis","volume":"45","author":"Goodman","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.10.015_bib19","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.10.015_bib20","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/hep.27173","article-title":"Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease","volume":"60","author":"Bedossa","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.10.015_bib21","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/hep.32475","article-title":"Reliability of histologic assessment for NAFLD and development of an expanded NAFLD activity score","volume":"76","author":"Pai","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.10.015_bib22","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1053\/j.gastro.2020.01.043","article-title":"Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"158","author":"Taylor","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2023.10.015_bib23","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.hep.2003.09.022","article-title":"Sampling variability of liver fibrosis in chronic hepatitis C","volume":"38","author":"Bedossa","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.10.015_bib24","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1053\/j.gastro.2005.03.084","article-title":"Sampling variability of liver biopsy in nonalcoholic fatty liver disease","volume":"128","author":"Ratziu","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2023.10.015_bib25","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.cgh.2007.06.005","article-title":"Histopathologic variability between the right and left lobes of the liver in morbidly obese patients undergoing Roux-en-Y bypass","volume":"5","author":"Larson","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2023.10.015_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2019.106651","article-title":"Variation in diagnostic NAFLD\/NASH read-outs in paired liver samples from rodent models","volume":"101","author":"Jensen","year":"2020","journal-title":"J\u00a0Pharmacol Toxicol Methods"},{"key":"10.1016\/j.jhep.2023.10.015_bib27","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.5858\/2000-124-1599-ROHC","article-title":"Regression of human cirrhosis. Morphologic features and the genesis of incomplete septal cirrhosis","volume":"124","author":"Wanless","year":"2000","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jhep.2023.10.015_bib28","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.jhep.2022.01.011","article-title":"Complexity of ballooned hepatocyte feature recognition: defining a training atlas for artificial intelligence-based imaging in NAFLD","volume":"76","author":"Brunt","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.10.015_bib29","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/path.5331","article-title":"Computational pathology definitions, best practices, and recommendations for regulatory guidance: a white paper from the Digital Pathology Association","volume":"249","author":"Abels","year":"2019","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.jhep.2023.10.015_bib30","doi-asserted-by":"crossref","first-page":"656","DOI":"10.5858\/arpa.2014-0073-OA","article-title":"Validation of multiple whole slide imaging scanners based on the guideline from the College of American Pathologists Pathology and Laboratory Quality Center","volume":"139","author":"Thrall","year":"2015","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jhep.2023.10.015_bib31","doi-asserted-by":"crossref","first-page":"222","DOI":"10.5858\/arpa.2018-0343-RA","article-title":"A\u00a0practical guide to whole slide imaging: a white paper from the digital pathology association","volume":"143","author":"Zarella","year":"2019","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jhep.2023.10.015_bib32","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/cjp2.227","article-title":"Reliable computational quantification of liver fibrosis is compromised by inherent staining variation","volume":"7","author":"Astbury","year":"2021","journal-title":"J\u00a0Pathol Clin Res"},{"key":"10.1016\/j.jhep.2023.10.015_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18081772","article-title":"Imaging collagen in scar tissue: developments in second harmonic generation microscopy for biomedical applications","volume":"18","author":"Mosta\u00e7o-Guidolin","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhep.2023.10.015_bib34","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1021\/ci050469j","article-title":"Are deterministic expert systems for computer-assisted structure elucidation obsolete?","volume":"46","author":"Elyashberg","year":"2006","journal-title":"J\u00a0Chem Inf Model"},{"key":"10.1016\/j.jhep.2023.10.015_bib35","doi-asserted-by":"crossref","first-page":"e253","DOI":"10.1016\/S1470-2045(19)30154-8","article-title":"Digital pathology and artificial intelligence","volume":"20","author":"Niazi","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jhep.2023.10.015_bib36","article-title":"From what to why, the growing need for a focus shift toward explainability of AI in digital pathology","volume":"12","author":"Border","year":"2021","journal-title":"Front Physiol"},{"key":"10.1016\/j.jhep.2023.10.015_bib37","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/j.ajpath.2020.10.018","article-title":"Challenges in the development, deployment, and regulation of artificial intelligence in anatomic pathology","volume":"191","author":"Cheng","year":"2021","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jhep.2023.10.015_bib38","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/j.cgh.2022.05.027","article-title":"Artificial intelligence improves pathologist agreement for fibrosis scores in nonalcoholic steatohepatitis patients","volume":"21","author":"Soon","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2023.10.015_bib39","article-title":"Digital pathology: advantages, limitations and emerging perspectives","volume":"9","author":"Jahn","year":"2020","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jhep.2023.10.015_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clinre.2019.07.009","article-title":"Quantitative SHG-microscopy: unraveling the nano-architecture of the cirrhotic liver","volume":"44","author":"Wanless","year":"2020","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.jhep.2023.10.015_bib41","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4103\/2153-3539.186902","article-title":"Deep learning for digital pathology image analysis: a comprehensive tutorial with selected use cases","volume":"7","author":"Janowczyk","year":"2016","journal-title":"J\u00a0Pathol Inform"},{"key":"10.1016\/j.jhep.2023.10.015_bib42","first-page":"A3788","article-title":"Machine learning-enabled continuous scoring of histologic features facilitates prediction of clinical disease progression in patients with non-alcoholic steatohepatitis","author":"Iyer","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.10.015_bib43","doi-asserted-by":"crossref","first-page":"S402","DOI":"10.1016\/S0168-8278(20)31289-7","article-title":"Machine learning models identify novel histologic features predictive of clinical disease progression in patients with advanced fibrosis due to non-alcoholic steatohepatitis","volume":"73","author":"Pokkalla","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2023.10.015_bib44","doi-asserted-by":"crossref","first-page":"S485","DOI":"10.1016\/S0168-8278(20)31451-3","article-title":"Machine learning models accurately interpret liver histology and are associated with disease progression in patients with primary sclerosing cholangitis","volume":"73","author":"Travis","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2023.10.015_bib45","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/hep.31750","article-title":"A\u00a0machine learning approach enables quantitative measurement of liver histology and disease monitoring in NASH","volume":"74","author":"Taylor-Weiner","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.10.015_bib46","series-title":"FDA authorizes software that can identify prostate cancer","author":"Us Food and Drug Administration","year":"2021"},{"key":"10.1016\/j.jhep.2023.10.015_bib47","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1177\/01926233211003866","article-title":"Microscope-based automated quantification of liver fibrosis in mice using a deep learning algorithm","volume":"49","author":"Ramot","year":"2021","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.jhep.2023.10.015_bib48","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1002\/hep.29090","article-title":"Dual-photon microscopy-based quantitation of fibrosis-related parameters (q-FP) to model disease progression in steatohepatitis","volume":"65","author":"Wang","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.10.015_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199166","article-title":"Second harmonic generation microscopy provides accurate automated staging of liver fibrosis in patients with non-alcoholic fatty liver disease","volume":"13","author":"Chang","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2023.10.015_bib50","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.humpath.2013.11.011","article-title":"Automatic classification of white regions in liver biopsies by supervised machine learning","volume":"45","author":"Vanderbeck","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jhep.2023.10.015_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197242","article-title":"Automated assessment of steatosis in murine fatty liver","volume":"13","author":"Sethunath","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2023.10.015_bib52","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/cyto.b.21790","article-title":"A\u00a0novel automatic digital algorithm that accurately quantifies steatosis in NAFLD on histopathological whole-slide images","volume":"96","author":"Munsterman","year":"2019","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/j.jhep.2023.10.015_bib53","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1038\/s41598-019-39783-1","article-title":"Quantification of hepatic steatosis in chronic liver disease using novel automated method of second harmonic generation and two-photon excited fluorescence","volume":"9","author":"Goh","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2023.10.015_bib54","first-page":"11","article-title":"Digital pathology enables automated and quantitative assessment of inflammatory activity in patients with chronic liver disease","author":"Marti-Aguado","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.jhep.2023.10.015_bib55","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/hep.30986","article-title":"qFIBS: an automated technique for quantitative evaluation of fibrosis, inflammation, ballooning, and steatosis in patients with nonalcoholic steatohepatitis","volume":"71","author":"Liu","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.10.015_bib56","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.humpath.2015.01.019","article-title":"Automatic quantification of lobular inflammation and hepatocyte ballooning in nonalcoholic fatty liver disease liver biopsies","volume":"46","author":"Vanderbeck","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jhep.2023.10.015_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmpb.2020.105614","article-title":"Computer-aided classification of hepatocellular ballooning in liver biopsies from patients with NASH using persistent homology","volume":"195","author":"Teramoto","year":"2020","journal-title":"Comput Methods Programs Biomed"},{"key":"10.1016\/j.jhep.2023.10.015_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2020.151518","article-title":"Automated quantification and architectural pattern detection of hepatic fibrosis in NAFLD","volume":"47","author":"Gawrieh","year":"2020","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.jhep.2023.10.015_bib59","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/apt.16100","article-title":"Digital pathology: accurate technique for quantitative assessment of histological features in metabolic-associated fatty liver disease","volume":"53","author":"Marti-Aguado","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2023.10.015_bib60","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41374-019-0315-9","article-title":"Automated computerized image analysis for the user-independent evaluation of disease severity in preclinical models of NAFLD\/NASH","volume":"100","author":"De Rudder","year":"2020","journal-title":"Lab Invest"},{"key":"10.1016\/j.jhep.2023.10.015_bib61","article-title":"An improved qFibrosis algorithm for precise screening and enrollment into non-alcoholic steatohepatitis (NASH) clinical trials","volume":"10","author":"Leow","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.jhep.2023.10.015_bib62","doi-asserted-by":"crossref","first-page":"S409","DOI":"10.1016\/S0168-8278(22)01159-X","article-title":"Machine learning encoding of liver biopsy images enables prediction of molecular measurements in a NASH F3\/F4 fibrosis clinical cohort","volume":"77","author":"Bereket","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.10.015_bib63","first-page":"954A","article-title":"Evidence for a robust artificial intelligence-based diagnostic support system in a clinical non-alcoholic fatty liver disease (NAFLD) scoring workflow","volume":"74","author":"Murugesan","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.10.015_bib64","doi-asserted-by":"crossref","first-page":"S682","DOI":"10.1016\/S0168-8278(20)31825-0","article-title":"Evaluation of pharmacological intervention using a deeplearning approach for histopathological scoring in a diet-induced obese and biopsy-confirmed mouse model of NASH with fibrosis","volume":"73","author":"Overgaard","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.10.015_bib65","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/S0168-8278(23)00486-5","article-title":"Analytical and clinical validation of AIM-NASH: a digital pathology tool for artificial intelligence-based measurement of nonalcoholic steatohepatitis histology","volume":"78","author":"Harrison","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2023.10.015_bib66","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/bioinformatics\/btp699","article-title":"Bisque: a platform for bioimage analysis and management","volume":"26","author":"Kvilekval","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jhep.2023.10.015_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmpb.2021.106453","article-title":"Blind color deconvolution, normalization, and classification of histological images using general super Gaussian priors and Bayesian inference","volume":"211","author":"P\u00e9rez-Bueno","year":"2021","journal-title":"Comput Methods Programs Biomed"},{"key":"10.1016\/j.jhep.2023.10.015_bib68","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.artmed.2018.10.004","article-title":"Computational normalization of H&E-stained histological images: progress, challenges and future potential","volume":"95","author":"Azevedo Tosta","year":"2019","journal-title":"Artif Intell Med"},{"key":"10.1016\/j.jhep.2023.10.015_bib69","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cmpb.2019.01.008","article-title":"Adaptive color deconvolution for histological WSI normalization","volume":"170","author":"Zheng","year":"2019","journal-title":"Comput Methods Programs Biomed"},{"key":"10.1016\/j.jhep.2023.10.015_bib70","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/abbs\/gmq129","article-title":"Texture analysis of liver fibrosis microscopic images: a study on the effect of biomarkers","volume":"43","author":"Amin","year":"2011","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"10.1016\/j.jhep.2023.10.015_bib71","unstructured":"FibroNest website."},{"key":"10.1016\/j.jhep.2023.10.015_bib72","first-page":"953A","article-title":"Evaluation of the multivendor performance of a novel histology-based fibrosis phenotypic composite score and its correlation with NASH-CRN fibrosis scores in patients with NASH","volume":"74","author":"Chen","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.10.015_bib73","doi-asserted-by":"crossref","first-page":"S482","DOI":"10.1016\/S0168-8278(22)01294-6","article-title":"Etiology-independent fibrosis severity scoring by quantitative digital pathology image analysis","volume":"77","author":"Watson","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2023.10.015_bib74","doi-asserted-by":"crossref","first-page":"S421","DOI":"10.1016\/S0168-8278(20)31326-X","article-title":"Evaluation of a novel histology-based fibrosis phenotypic composite score and its correlation with NASH-CRN fibrosis scores in patients with NASH","volume":"73","author":"L","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.10.015_bib75","first-page":"1135A","article-title":"Digital pathology image analysis accurately quantifies anti-fibrotic and anti-steatotic effects of FXR agonists using multiple histological methods","volume":"74","author":"L","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.10.015_bib76","first-page":"470A","article-title":"Development of an optimal continuous pediatric fibrosis score to assess severity and progression of fibrosis in non-alcoholic fatty liver disease (NAFLD)","volume":"70","author":"Reynoso","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.10.015_bib77","first-page":"1021A","article-title":"Is the histological phenotype of fibrosis different between lean and obese NASH patients?","volume":"74","author":"Iwaki","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.10.015_bib78","first-page":"945A","article-title":"Continuous staging of NASH patients at low (F1) fibrosis severity: evaluation of the performance of a novel histology-based fibrosis phenotypic composite score and predictive AI tools","volume":"74","author":"L","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.10.015_bib79","doi-asserted-by":"crossref","first-page":"S439","DOI":"10.1016\/S0168-8278(22)01214-4","article-title":"Evaluation of the performance of a novel digital pathology method for the continuous quantification of steatosis, ballooning and inflammation in liver biopsies and its correlation with NASH-CRN scores in patients with NASH","volume":"77","author":"Petitjean","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.10.015_bib80","doi-asserted-by":"crossref","DOI":"10.1117\/1.3183811","article-title":"Fibro-C-Index: comprehensive, morphology-based quantification of liver fibrosis using second harmonic generation and two-photon microscopy","volume":"14","author":"Tai","year":"2009","journal-title":"J\u00a0Biomed Opt"},{"key":"10.1016\/j.jhep.2023.10.015_bib81","doi-asserted-by":"crossref","DOI":"10.1117\/1.3041159","article-title":"Nonlinear optical microscopy: use of second harmonic generation and two-photon microscopy for automated quantitative liver fibrosis studies","volume":"13","author":"Sun","year":"2008","journal-title":"J\u00a0Biomed Opt"},{"key":"10.1016\/j.jhep.2023.10.015_bib82","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1136\/gutjnl-2019-318841","article-title":"Quantifying and monitoring fibrosis in non-alcoholic fatty liver disease using dual-photon microscopy","volume":"69","author":"Wang","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2023.10.015_bib83","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3350\/cmh.2020.0181","article-title":"Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: histological perspective","volume":"27","author":"Soon","year":"2021","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jhep.2023.10.015_bib84","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.jhep.2022.06.018","article-title":"Digital pathology with artificial intelligence analyses provides greater insights into treatment-induced fibrosis regression in NASH","volume":"77","author":"Naoumov","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.10.015_bib85","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/apt.17363","article-title":"Machine learning liver histology scores correlate with portal hypertension assessments in nonalcoholic steatohepatitis cirrhosis","volume":"57","author":"Noureddin","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2023.10.015_bib86","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jhep.2014.02.015","article-title":"qFibrosis: a fully-quantitative innovative method incorporating histological features to facilitate accurate fibrosis scoring in animal model and chronic hepatitis B patients","volume":"61","author":"Xu","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.10.015_bib87","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jhep.2009.12.009","article-title":"Fibrillar collagen scoring by second harmonic microscopy: a new tool in the assessment of liver fibrosis","volume":"52","author":"Gailhouste","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.10.015_bib88","first-page":"2023","author":"Naoumov","year":"2023","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.10.015_bib89","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/S0140-6736(19)32517-6","article-title":"Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"394","author":"Harrison","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2023.10.015_bib90","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/S0168-8278(22)00476-7","article-title":"Impact of resmetirom-mediated reductions in liver volume and steatosis compared with placebo on the quantification of fibrosis using second harmonic generation in a serial liver biopsy study","volume":"77","author":"Tai","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.10.015_bib91","first-page":"S602","article-title":"Liver biopsy graph neural networks for automated histologic scoring using the NASH CRN system","volume":"75","author":"Wang","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.10.015_bib92","doi-asserted-by":"crossref","first-page":"S711","DOI":"10.1016\/S0168-8278(22)01740-8","article-title":"Retrospective AI-based measurement of NASH histology (AIM-NASH) analysis of biopsies from Phase 2 study of resmetirom confirms significant treatment-induced changes in histologic features of non-alcoholic steatohepatitis","volume":"77","author":"Harrison","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.10.015_bib93","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/hep.31622","article-title":"Combination therapies including cilofexor and firsocostat for bridging fibrosis and cirrhosis attributable to NASH","volume":"73","author":"Loomba","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.10.015_bib94","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMoa2028395","article-title":"A\u00a0placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis","volume":"384","author":"Newsome","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2023.10.015_bib95","first-page":"1131A","article-title":"Artificial intelligence-powered digital pathology model supports that fibrosis is reduced by semaglutide in patients with NASH","volume":"74","author":"Harrison","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.10.015_bib96","first-page":"76","article-title":"Comparison of the effects of semaglutide on liver histology in patients with non-alcoholic steatohepatitis cirrhosis between machine learning model assessment and pathologist evaluation","author":"Loomba","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.10.015_bib97","first-page":"74","article-title":"Comparison of manual vs machine learning approaches to liver biopsy scoring for NASH and fibrosis: a post hoc analysis of the FALCON 1 study","author":"Shevell","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.10.015_bib98","doi-asserted-by":"crossref","first-page":"S714","DOI":"10.1016\/S0168-8278(22)01745-7","article-title":"Multimodality assessment of hepatic fibrosis: ranked paired reading and artificial intelligence identifies fibrosis improvement with aramchol missed by conventional staging","volume":"77","author":"Ratziu","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.10.015_bib99","doi-asserted-by":"crossref","first-page":"S446","DOI":"10.1016\/S0168-8278(22)01227-2","article-title":"Novel digital pathology quantitative image analysis and AI method detects the treatment effects of NASH drug candidates with\u00a0a\u00a0performance that benchmarks imaging-based measurements","volume":"77","author":"L","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.10.015_bib100","first-page":"78","article-title":"Novel Digital Pathology quantitative image analysis and AI method detects traits of fibrosis treatment response","author":"Chen","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.10.015_bib101","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/S0168-8278(23)00540-8","article-title":"Digital pathology using stain-free imaging indices allows direct prediction of all-cause mortality, hepatic decompensation and hepatocellular carcinoma development in patients with non-alcoholic fatty liver disease","volume":"78","author":"Kendall","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2023.10.015_bib102","doi-asserted-by":"crossref","first-page":"S651","DOI":"10.1016\/S0168-8278(23)02001-9","article-title":"Novel artificial intelligence-assisted digital pathology quantitative image analysis predicts the occurrence of liver-related clinical events in the multicentric, European, Hepatic OuTcomes and SURvival Fatty Liver Registry (HOTSURFR) study","volume":"78","author":"Chen","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2023.10.015_bib103","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1002\/hep.32087","article-title":"A\u00a0machine learning approach to liver histological evaluation predicts clinically significant portal hypertension in NASH cirrhosis","volume":"74","author":"Bosch","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.10.015_bib104","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s12072-022-10340-9","article-title":"Automated fibrosis phenotyping of liver tissue from non-tumor lesions of patients with and without hepatocellular carcinoma after liver transplantation for non-alcoholic fatty liver disease","volume":"16","author":"Nakamura","year":"2022","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhep.2023.10.015_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110454","article-title":"Distinct hepatic immunological patterns are associated with the progression or inhibition of hepatocellular carcinoma","volume":"38","author":"Mirshahi","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.jhep.2023.10.015_bib106","doi-asserted-by":"crossref","first-page":"S688","DOI":"10.1016\/S0168-8278(22)01694-4","article-title":"Advanced quantitative phenotypic fibrosis and steatosis scoring is more superior to histology-based conventional staging in NASH animal models","volume":"77","author":"Chen","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.10.015_bib107","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.add3949","article-title":"An autocrine signaling circuit in hepatic stellate cells underlies advanced fibrosis in nonalcoholic steatohepatitis","volume":"15","author":"Wang","year":"2023","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jhep.2023.10.015_bib108","doi-asserted-by":"crossref","first-page":"G408","DOI":"10.1152\/ajpgi.00061.2019","article-title":"Exogenous PP2A inhibitor exacerbates the progression of nonalcoholic fatty liver disease via NOX2-dependent activation of miR21","volume":"317","author":"Albadrani","year":"2019","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2023.10.015_bib109","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jcmgh.2020.04.010","article-title":"Diet reversal and immune modulation show key role for liver and adipose tissue T cells in murine nonalcoholic steatohepatitis","volume":"10","author":"Van Herck","year":"2020","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2023.10.015_bib110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082163","article-title":"Hepatic crown-like structure: a unique histological feature in non-alcoholic steatohepatitis in mice and humans","volume":"8","author":"Itoh","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2023.10.015_bib111","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/labinvest.2016.128","article-title":"Automated evaluation of liver fibrosis in thioacetamide, carbon tetrachloride, and bile duct ligation rodent models using second-harmonic generation\/two-photon excited fluorescence microscopy","volume":"97","author":"Liu","year":"2017","journal-title":"Lab Invest"},{"key":"10.1016\/j.jhep.2023.10.015_bib112","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/hep4.1270","article-title":"Obeticholic acid modulates serum metabolites and gene signatures characteristic of human NASH and attenuates inflammation and fibrosis progression in Ldlr-\/-.Leiden mice","volume":"2","author":"Morrison","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhep.2023.10.015_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154873","article-title":"Diet and exercise reduce pre-existing NASH and fibrosis and have additional beneficial effects on the vasculature, adipose tissue and skeletal muscle via organ-crosstalk","volume":"124","author":"van den Hoek","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.jhep.2023.10.015_bib114","doi-asserted-by":"crossref","first-page":"S446","DOI":"10.1016\/S0168-8278(22)01227-2","article-title":"Novel Digital Pathology quantitative image analysis and AI method detects the treatment effect of NASH drug candidates with a performance that benchmarks Imaging based measurements","volume":"77","author":"Chen","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.10.015_bib115","article-title":"Exploratory analyses of NASH histology using CRN scores derived from a multi-stain machine learning method","volume":"76","author":"Abel","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.10.015_bib116","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1109\/TMI.2020.3021387","article-title":"Pathomic fusion: an integrated framework for fusing histopathology and genomic features for cancer diagnosis and prognosis","volume":"41","author":"Chen","year":"2022","journal-title":"IEEE Trans Med Imaging"},{"key":"10.1016\/j.jhep.2023.10.015_bib117","first-page":"358A","article-title":"Integration of machine learning-based histopathology and hepatic transcriptomic data identifies genes associated with portal inflammation and ductular proliferation as predictors of disease progression in advanced fibrosis due to NASH","volume":"72","author":"Pourhyaya","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.10.015_bib118","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4103\/jpi.jpi_33_18","article-title":"New European union regulations related to whole slide image scanners and image analysis software","volume":"10","author":"Garc\u00eda-Rojo","year":"2019","journal-title":"J\u00a0Pathol Inform"},{"key":"10.1016\/j.jhep.2023.10.015_bib119","article-title":"Bridging the gap: the critical role of regulatory affairs and clinical affairs in the total product life cycle of pathology imaging devices and software","volume":"8","author":"Kearney","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jhep.2023.10.015_bib120","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/path.5310","article-title":"Artificial intelligence in digital pathology: a roadmap to routine use in clinical practice","volume":"249","author":"Colling","year":"2019","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.jhep.2023.10.015_bib121","series-title":"Medical device data systems, medical\u00a0image storage devices, and medical image communications devices. Guidance for industry and Food nd drug administration staff","author":"Us Food and Drug Administration","year":"2019"},{"key":"10.1016\/j.jhep.2023.10.015_bib122","series-title":"Artificial intelligence\/machine learning (AI\/ML)-based software as a medical device (SaMD) action plan","author":"Us Food and Drug Administration","year":"2021"},{"key":"10.1016\/j.jhep.2023.10.015_bib123","article-title":"Developing a new qFIBS model assessing histological features in pediatric patients with non-alcoholic steatohepatitis","volume":"9","author":"Liu","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jhep.2023.10.015_bib124","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MPG.0000000000001482","volume":"64","author":"Vos","year":"2017","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827823051826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827823051826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T17:10:57Z","timestamp":1739553057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827823051826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":124,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0168827823051826"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2023.10.015","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Artificial intelligence-assisted digital pathology for non-alcoholic steatohepatitis: current status and future directions","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2023.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}